Clinical pharmacokinetic of celecoxib in healthy Thai volunteers

Journal of the Medical Association of Thailand

Volumn 88, Issue 5, 2005, Pages 632-638

  Itthipanichpong, Chandhanee ^a   Chompootaweep, Sumana ^a   Wittayalertpanya, Supeecha ^a   Kemsri, Wandee ^a   Thaworn, Nongnuch ^a   Lilitkarntrakul, Pajaree ^a   Parikamsil, Sithiporn ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Celecoxib; Pharmacokinetic

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG SAFETY; DRUG TRANSFORMATION; HUMAN; MALE; NORMAL HUMAN; REVERSED PHASE LIQUID CHROMATOGRAPHY; THAILAND; TIME SERIES ANALYSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; PYRAZOLES; REFERENCE VALUES; SULFONAMIDES; THAILAND;

EID: 23044488526     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Clemett D, Goa KL. Celecoxib. A review of its use in osteoarthritis, rheumatoid arthritis and acute pain. Drug 2000; 59: 957-80.
2. Davies NM, McLachlan AJ, Day RO, Williams KM. Clinical pharmacokinetics and pharmacodynamics of celecoxib a selective cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 2000; 38: 225-42.
3. Fitz-Gerald GA, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. New Engl J Med 2001; 345: 433-42.
4. Tang C, Shou M, Mei Q, Rushmore TH, Rodrigues AD. Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor. J Pharm Exp Ther 2000; 293: 453-9.
5. Johnson JA. Influence of race or ethnicity on pharmacokinetics of drugs. J Pharm Sci 1997; 86: 1328-33.
6. Johnson JA. Predictability of the effects of race or ethnicity on pharmacokinetic of drugs. Int J Clin Pharmacol Ther 2000; 38: 53-60.
7. Schonberger F, Heinkele G, Murdter TE, Brenner S, Klotz U. Simple and sensitive method for the determination of celecoxib in human serum by high-performance liquid chromatography with fluorescence detector. J Chromatograph B 2002; 768: 255-60.
8. Capone ML, Tacconelli S, Sciulli MG, Patrignani P. Clinical pharmacology of selective COX-2 inhibitors. Int J Immunopathol Pharmacol 2003; 16(Suppl 2): 49-58.
9. Paulson SK, Vaughn MB, Tessen SM, Lawal Y, Greask CJ, Yan B, et al. Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption. J Pharm Exp Ther 2001; 297: 638-45.
10. 14C) celecoxib in healthy male volunteers. Drug Metab Dispos 2000; 28: 308-14.
11. GD Searle and Company. Celecoxib prescribing information. Skokie Illinois, 1999; 23.
12. Jayasagar G, Krishna Kumar M, Chandrasekhar K, Madhusudan Rao Y. Influence of rifampicin pretreatment on the pharmacokinetics of celecoxib in healthy male volunteers. Drug Metabol Drug Interact 2003; 19: 287-95.